Related Experiment Video
Updated: Jul 10, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Synthetic chemistry-led creation of a difluorinated biaryl ether non-nucleoside reverse transcriptase inhibitor
Lyn H Jones1, Amy Randall, Oscar Barba
1Discovery Chemistry, Sandwich Laboratories, Pfizer Global Research and Development, Ramsgate Road, Sandwich, Kent, UK CT13 9NJ. lyn.jones@pfizer.com
Abstract:
In the process of developing a series of novel, fluorinated biaryl ether NNRTIs, we fortuitously discovered derivative 20, which possesses excellent potency against both wild-type and clinically relevant mutations of the reverse transcriptase enzyme.
More Related Videos
08:46Regioselective O-Glycosylation of Nucleosides via the Temporary 2',3'-Diol Protection by a Boronic Ester for the Synthesis of Disaccharide Nucleosides
Published on: July 26, 2018
06:34Synthesis of Antiviral Tetrahydrocarbazole Derivatives by Photochemical and Acid-catalyzed C-H Functionalization via Intermediate Peroxides (CHIPS)
Published on: June 20, 2014
Related Concept Videos
Antiviral Nucleoside Inhibitors
Electrophilic Aromatic Substitution: Fluorination and Iodination of Benzene
Viruses with RNA Genomes
Synthetic Biology
Golden rice
Golden rice is a genetically modified...
Inhibitors of Viral Protein Synthesis
Retrovirus Life Cycles